Russia sanctions: what next for Sputnik Covid-19 vaccine production around the world?
The Russian invasion of Ukraine has knock-on effects on the Covid-19 pandemic as supplies of Sputnik V vaccine to Asian,…
By
Manufacturing
Latest in
Manufacturing
Myelofibrosis market to see new approvals in 2022, driving market growth
Several novel agents for myelofibrosis are entering late-phase clinical development with a view to being launched on the market.
By
UNION’s orismilast enters Phase IIb and a crowded small molecule market
If approved, orismilast would be the second oral phosphodiesterase-4 inhibitor to enter the plaque psoriasis space.
By
Is precision medicine the future of obesity treatment?
Findings from a recent study could aid in the development of precision medicines for conditions such as obesity.
By
National Thyroid Awareness Month shines a spotlight on disorders like hypothyroidism
Increasing awareness of hypothyroidism and other thyroid disorders represents an important public health strategy.
By
Global warning: pharma’s role in the climate crisis
With COP26 imminent, what lessons can the pharma sector learn about its environmental impact and its response to climate change?
By
Valneva could outsource Covid-19 vaccine manufacturing in response to demand
Valneva maps authorisation and manufacturing plans on the heels of positive Phase III Covid-19 vaccine data.
By
Novavax at risk of losing time advantage once Covid-19 vaccine competitors flex production muscle
Competitor protein subunit Covid-19 vaccine manufacturers are slowly closing in at Novavax’s lead.
By